|
|
|
|
|
|
03.17.08:
Health Advances Supports American Cancer Society Fundraising Event
Since its inception, Health Advances has devoted one day per quarter for our entire staff to participate in community service. For the fourth year in a row, employees of Health Advances contributed their time and
talent to "Daffodil Days," a major fundraising event for the American Cancer Society.
03.10.08:
Health Advances Launches New Corporate Image
Health Advances is pleased to unveil a new corporate image package. This includes our new format for corporate communications,
updated corporate website, and, most prominently, our new logo. Our new website provides more information for clients and recruits.
Emphasizing fresh, practical perspectives and new ideas, our new image reflects the values we strive to deliver to our clients.
01.21.08:
Health Advances Strengthens Management Team
Margaret Kemp Carlson joins Health Advances in the newly created role of Chief Operating Officer from Colliers International,
a $1.6B commercial real estate services company with 250 offices worldwide. As a key member of the senior leadership team,
Ms. Carlson is responsible for directing a wide range of functional resources necessary to deliver the highest quality
consulting services to our clients. "We are exceptionally pleased to have recruited someone of Ms. Carlson's caliber to
our firm. This role and Ms. Carlson's contribution will further enhance our ability to provide best-in-class services and
allow my partners and me even greater focus on the needs of our clients and their challenges. It is critical for sustaining
the growth of our firm," says Mark Speers, Partner and Managing Director.
01.01.08:
Kristin Pothier and Donna Hochberg Author Article for InVivo Magazine
Health Advances is pleased to announce the publication of the article
"Biomarker Diagnostics: Place Your Bets Wisely" by Kristin Pothier, Vice President and Donna Hochberg, Associate in the January 2008 issue
of In Vivo, a strategic business journal for the biopharma, med-tech, diagnostics and hospital supply industries. The abstract is as follows:
Biomarker diagnostics are the linchpin of personalized medicine. But building a successful business around such tests is anything but
straightforward, given the complexities associated with both their development and commercialization. Today's molecular diagnostic companies
need to think carefully before they choose a "go it alone" strategy when developing a particular test. It may make more sense to forge a
partnership with another diagnostic company or a drug developer with the goal of sharing costs and relative risks.
 request a reprint
10.03.07:
Skip Irving Appointed to Michael J. Fox Foundation for Parkinson's Research Board of Directors
For several years, Skip has been advising the Michael J. Fox Foundation on its strategy for engaging both large and small companies
in partnerships to develop novel Parkinson's therapeutics. In joining the Board, Skip will provide ongoing support for the further
pursuit of this strategy. The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease
within the decade through an aggressively funded research agenda.
|
|
 |
|
|
|
|
